Assessment & Research

Virtual rescripting after loss using deepfake technology in prolonged grief treatment: a study protocol for a multiple baseline design

Petkovski et al. (2026) · European Journal of Psychotraumatology 2026
★ The Verdict

Deepfake-assisted virtual rescripting for grief is still experimental—wait for the data before adopting.

✓ Read this if BCBAs who follow novel exposure-based or technology-enhanced therapies for adult clients with prolonged grief.
✗ Skip if Clinicians looking for ready-to-use grief interventions today.

01Research in Context

01

What this study did

Petkovski et al. (2026) wrote a plan for a nine-person study. They will test a new grief therapy that uses deepfake video to let clients "rescript" painful memories.

The team will run a multiple-baseline design across adults with prolonged grief. Each person starts therapy at a different time so the researchers can see if changes line up with treatment.

02

What they found

Nothing yet. This paper only gives the recipe, not the cake. Outcomes will come later.

03

How this fits with other research

Bhaumik et al. (2008) used the same multiple-baseline recipe to treat chronic fatigue. Their fatigue scores dropped after therapy and stayed low for months. Petkovski copies the design but swaps the target from fatigue to grief.

Fanning Tacoaman et al. (2024) also ran a multiple baseline, but to teach staff how to pair with kids. Both studies show the design works across very different goals—staff skills, fatigue, and now grief.

Renne et al. (1976) proved the design can handle tough clinical problems like schizophrenia. Petkovski’s grief study extends that lineage into new tech territory.

04

Why it matters

If the data later show drops in grief scores right after each person starts deepfake sessions, you’ll have early evidence that virtual rescripting works. Until then, keep the idea on your radar but stick to grief tools with proven track records.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Bookmark the paper and set a calendar reminder to search for follow-up results in one year.

02At a glance

Intervention
other
Design
multiple baseline across participants
Sample size
9
Population
other
Finding
not reported

03Original abstract

Background: Prolonged grief disorder (PGD) is characterized by severe and persistent grief that impairs daily functioning. Cognitive behavioural therapy is the first-line treatment but yields only small-to-moderate effects. Imagery rescripting, which targets distressing loss-related memories, is increasingly used for PGD and related trauma complaints. Incorporating deepfake technology into imagery rescripting, i.e. virtual rescripting, may increase emotional engagement and facilitate processing of the loss, potentially improving treatment outcomes. However, this approach has not yet been empirically examined for PGD. Objective: This study aims to explore the potential effectiveness of virtual rescripting in reducing prolonged grief intensity, loss-related unfinished business, grief rumination, guilt, regret, and negative affect, and increasing well-being and positive affect. Methods: A multiple baseline design will be employed (ethics ID: NL-010145). Nine participants will be randomly assigned to a baseline length of five, six, or seven weeks. The intervention phase will span five weeks and include three therapist-guided sessions: (1) introduction, (2) virtual rescripting, and (3) evaluation. Participants will complete weekly questionnaires during both the baseline and intervention phases. Data will be analyzed using randomization tests to compare the intensity levels of the outcomes of interest between the baseline and intervention phases. Conclusions: This is the first study to explore the potential effectiveness of virtual rescripting in PGD treatment, providing preliminary evidence for future large-scale trials to improve bereavement care.

European Journal of Psychotraumatology, 2026 · doi:10.1080/20008066.2026.2643984